Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vitronectin receptor antagonist pharmaceuticals

Vitronectin receptor antagonist pharmaceuticals

US Patent 7018611 · Granted Mar 28, 2006

Estimated economic value: $102,743,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chemotherapy induced neutropenia using fixed doses of eflape2024
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels2019
Methods and compositions for identifying subjects at risk of developing stent th2018
Fluorescent imaging agents2018
Biocompatible fluorescent metal oxide nanoparticles2018
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2017
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels2017
Fluorescent imaging agents2016
Methods and compositions for identifying subjects at risk of developing stent th2014
Fluorescent imaging agents2014
Nicotinic acid and picolinic acid derived near-infrared fluorophores2014
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2014